)

Bicycle Therapeutics (BCYC) investor relations material
Bicycle Therapeutics Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Board and leadership updates
Two new board members with extensive oncology experience were appointed, enhancing expertise in drug development and commercialization.
Recent board additions aim to build a world-class oncology-focused organization.
The board now includes leaders with backgrounds in translational oncology, drug development, and commercial enterprise.
Pipeline and clinical development insights
Zelanectide, a bicycle drug conjugate, shows strong efficacy and a differentiated safety profile in metastatic urothelial cancer.
Phase 1 data indicate comparable efficacy to PADCEV with lower rates of severe skin toxicity and milder, reversible neuropathy.
Market research shows 84% of surveyed oncologists would recommend zelanectide plus EBP over EVP, indicating strong physician support.
Pivotal DURAVELO II trial design incorporates learnings from Phase 1, focusing on broad patient inclusion and competitive endpoints.
Interim data and dose selection updates are expected after a planned FDA meeting in Q4, with a qualitative release anticipated.
Expansion into new indications and diagnostics
Nectin-4 amplification identified as a key biomarker in bladder, lung, and breast cancers, with response rates up to 50-60% in amplified patients.
Phase 2 studies in breast and lung cancer are ongoing, selecting patients based on Nectin-4 expression and developing companion diagnostics.
Companion diagnostics using FISH and NGS are being developed to support targeted therapy in these indications.
Next Bicycle Therapeutics earnings date

Next Bicycle Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage